Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A B Sandler

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of Endodontics|November 1, 1992
Apical dye penetration with four root canal sealers and gutta-percha using longitudinal sectioningS Limkangwalmongkol, P V Abbott, A B Sandler
The Journal of General Virology|February 1, 1996
Sp1 is critical for basal and E2-transactivated transcription from the bovine papillomavirus type 1 P89 promoterA B Sandler, C C Baker, B A Spalholz
Journal of Endodontics|June 1, 1980
Intentional replantation: a case reportE S Rosenberg, L E Rossman, A B Sandler
Journal of Virology|September 1, 1993
Repression of bovine papillomavirus type 1 transcription by the E1 replication proteinA B Sandler, S B Vande Pol, B A Spalholz
American Journal of Clinical Oncology|December 22, 1999
A phase II study of carboplatin plus gemcitabine in advanced non-small-cell lung cancer (NSCLC): a hoosier oncology group studyE W Ng, A B Sandler, L Robinson, et al.
Cancer Investigation|January 1, 1996
A phase I pilot study of BCNU plus thymidine in patients with refractory cancerM Z Schultz, A B Sandler, H J Durivage, et al.
Cancer|August 1, 1992
Disseminated intravascular coagulation and excessive fibrinolysis in a patient with metastatic prostate cancer. Response to epsilon-aminocaproic acidD L Cooper, A B Sandler, L D Wilson, et al.
Journal of Endodontics|October 1, 1991
A comparative study of the apical leakage of four root canal sealers and laterally condensed gutta-perchaS Limkangwalmongkol, P Burtscher, P V Abbott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group TrialE A Faylona, P J Loehrer, R Ansari, et al.
Cancer|April 7, 1998
A phase II trial of paclitaxel in refractory germ cell tumorsA B Sandler, A Cristou, S Fox, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Endodontics|November 1, 1992
Apical dye penetration with four root canal sealers and gutta-percha using longitudinal sectioningS Limkangwalmongkol, P V Abbott, A B Sandler
The Journal of General Virology|February 1, 1996
Sp1 is critical for basal and E2-transactivated transcription from the bovine papillomavirus type 1 P89 promoterA B Sandler, C C Baker, B A Spalholz
Journal of Endodontics|June 1, 1980
Intentional replantation: a case reportE S Rosenberg, L E Rossman, A B Sandler
Journal of Virology|September 1, 1993
Repression of bovine papillomavirus type 1 transcription by the E1 replication proteinA B Sandler, S B Vande Pol, B A Spalholz
American Journal of Clinical Oncology|December 22, 1999
A phase II study of carboplatin plus gemcitabine in advanced non-small-cell lung cancer (NSCLC): a hoosier oncology group studyE W Ng, A B Sandler, L Robinson, et al.
Cancer Investigation|January 1, 1996
A phase I pilot study of BCNU plus thymidine in patients with refractory cancerM Z Schultz, A B Sandler, H J Durivage, et al.
Cancer|August 1, 1992
Disseminated intravascular coagulation and excessive fibrinolysis in a patient with metastatic prostate cancer. Response to epsilon-aminocaproic acidD L Cooper, A B Sandler, L D Wilson, et al.
Journal of Endodontics|October 1, 1991
A comparative study of the apical leakage of four root canal sealers and laterally condensed gutta-perchaS Limkangwalmongkol, P Burtscher, P V Abbott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group TrialE A Faylona, P J Loehrer, R Ansari, et al.
Cancer|April 7, 1998
A phase II trial of paclitaxel in refractory germ cell tumorsA B Sandler, A Cristou, S Fox, et al.
Pageof 4